XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Non-voting Common Stock
Common Stock
Common Stock
Non-voting Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balances at Dec. 31, 2021 $ 160,778   $ 2 $ 1 $ 252,933 $ (92,158)
Balances, shares at Dec. 31, 2021     18,764,463 5,143,134    
Exercise of stock options 119       119  
Exercise of stock options, shares     48,501      
Vesting of restricted common stock, shares     116,870      
Stock-based compensation expense 2,008       2,008  
Net loss (31,253)         (31,253)
Balances at Jun. 30, 2022 131,652   $ 2 $ 1 255,060 (123,411)
Balances, shares at Jun. 30, 2022     18,929,834 5,143,134    
Balances at Mar. 31, 2022 145,694   $ 2 $ 1 254,005 (108,314)
Balances, shares at Mar. 31, 2022     18,888,085 5,143,134    
Exercise of stock options 31       31  
Exercise of stock options, shares     12,530      
Vesting of restricted common stock, shares     29,219      
Stock-based compensation expense 1,024       1,024  
Net loss (15,097)         (15,097)
Balances at Jun. 30, 2022 131,652   $ 2 $ 1 255,060 (123,411)
Balances, shares at Jun. 30, 2022     18,929,834 5,143,134    
Balances at Dec. 31, 2022 99,434   $ 2 $ 1 257,810 (158,379)
Balances, shares at Dec. 31, 2022   5,143,134 19,082,820 5,143,134    
Exercise of stock options 682       682  
Exercise of stock options, shares     305,678      
Issuance of common stock, net of offering costs 42,414   $ 2   42,412  
Issuance of common stock, net of offering costs, shares     23,287,134      
Issuance of pre-funded warrants, net of offering costs 92,318       92,318  
Conversion of non-voting common stock to voting common stock     866,546 (866,546)    
Stock-based compensation expense 2,367       2,367  
Net loss (46,608)         (46,608)
Balances at Jun. 30, 2023 190,607   $ 4 $ 1 395,589 (204,987)
Balances, shares at Jun. 30, 2023   4,276,588 43,542,178 4,276,588    
Balances at Mar. 31, 2023 78,018   $ 2 $ 1 258,957 (180,942)
Balances, shares at Mar. 31, 2023     19,480,729 4,745,225    
Exercise of stock options 682       682  
Exercise of stock options, shares     305,678      
Issuance of common stock, net of offering costs 42,414   $ 2   42,412  
Issuance of common stock, net of offering costs, shares     23,287,134      
Issuance of pre-funded warrants, net of offering costs 92,318       92,318  
Conversion of non-voting common stock to voting common stock     468,637 (468,637)    
Stock-based compensation expense 1,220       1,220  
Net loss (24,045)         (24,045)
Balances at Jun. 30, 2023 $ 190,607   $ 4 $ 1 $ 395,589 $ (204,987)
Balances, shares at Jun. 30, 2023   4,276,588 43,542,178 4,276,588